PPI Cases To Proceed as Per The New Deadlines Ordered

Introduction

Going forward, Proton Pump Inhibitor (PPI) cases will follow a number of new deadlines ordered by the federal court post the 5th Case Management Conference scheduled this November. Nearly 300 PPI cases are filed in the District of New Jersey by patients who developed renal issues allegedly linked to PPI usage. The drugs include Nexium, Prilosec, PrevAcid, and others.

Allegations hurled by the plaintiffs include that the defendants knew of the kidney failure and other kidney complications, yet failed to provide the patients and doctors with appropriate warnings.

All federally-filed PPI lawsuits were centralized in the District of New Jersey, for coordinated discovery and other pretrial proceedings in August, earlier this year, before Judge Claire C. Cecchi.

Comments

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

PPI Cases To Proceed as Per The New Deadlines Ordered